Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-14-000152

← back to feed
Filed
Aug 19, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 18, 2014 82.33M sh
Shares Diluted Q2 2014 · Jun 30, 2014 82.33M sh
Shares Diluted Q2 2014 · Jun 30, 2014 82.33M sh
Shares Diluted Q2 2014 · Jun 30, 2013 82.33M sh
Shares Diluted Q2 2014 · Jun 30, 2013 82.33M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$20.91K
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$5.98M
Operating Cash Flow restated Q2 2014 · Jun 30, 2013 −$41.52K
Stockholders Equity Q2 2014 · Jun 30, 2014 −$888.44K
Stockholders Equity Q2 2014 · Dec 31, 2013 −$819.8K
Current Liabilities Q2 2014 · Jun 30, 2014 $365.28K
Current Liabilities Q2 2014 · Dec 31, 2013 $351.34K
Total Liabilities Q2 2014 · Jun 30, 2014 $889.43K
Total Liabilities Q2 2014 · Dec 31, 2013 $828.83K
Current Assets Q2 2014 · Jun 30, 2014 $993
Current Assets Q2 2014 · Dec 31, 2013 $9.03K
Total Assets Q2 2014 · Jun 30, 2014 $993
Total Assets Q2 2014 · Dec 31, 2013 $9.03K
Sga Expense Q2 2014 · Jun 30, 2014 $3.1K
Sga Expense Q2 2014 · Jun 30, 2014 $15.15K
Sga Expense Q2 2014 · Jun 30, 2014 $2.68M
Sga Expense Q2 2014 · Jun 30, 2013 $13.96K
Sga Expense Q2 2014 · Jun 30, 2013 $26.43K
Rd Expense Q2 2014 · Jun 30, 2014 $1.3M
Net Income Q2 2014 · Jun 30, 2014 −$35.85K
Net Income Q2 2014 · Jun 30, 2014 −$68.64K
Net Income Q2 2014 · Jun 30, 2014 −$12.75M
Net Income Q2 2014 · Jun 30, 2013 −$48.81K
Net Income Q2 2014 · Jun 30, 2013 −$84.08K